Eric Topol· @EricTopol · X·· 3 小时前AI 评分52
AI 导读
Eric Topol 引用一项预印本研究指出，司美格鲁肽（Ozempic）在5项安慰剂对照试验中，使心脏、动脉和肾脏时钟的蛋白组学器官年龄一致降低2-4年。相关结果发布于 researchsquare.com/article/rs-11082091/v1。
正文
Semaglutide (Ozempic) consistently reduced proteomic organ age 2-4 years for the heart, artery, and kidney clocks across 5 placebo-controlled trials
https://www.researchsquare.com/article/rs-11082091/v1
来源：Eric Topol · x.com